Skin Dermatomyositis with Concurrent Cutaneous Tuberculosis. A Clinical Case
https://doi.org/10.58838/2075-1230-2025-103-3-103-108
Abstract
This article describes a clinical case of an extremely rare combination of two nosological types of skin lesions – dermatosis and cutaneous tuberculosis. It presents stages of diagnosis, which took 6 years and difficulties when choosing treatment. During the combination treatment (corticosteroids, anti-tuberculosis drugs, and other medications), PATE developed, leading to a fatal outcome.
About the Authors
R. G. KovalevaRussian Federation
Raisa G. Kovaleva, Candidate of Medical Sciences, Associate Professor of Phthisiopulmonology and Thoracic Surgery Department
47 Piskarevsky Ave., St. Petersburg, 190567
Phone: + 7 (812) 303-50-00
M. N. Kondakova
Russian Federation
Marina N. Kondakova, Doctor of Medical Sciences, Professor of Phthisiopulmonology and Thoracic Surgery Department
47 Piskarevsky Ave., St. Petersburg, 190567
Phone: + 7 (812) 303-50-00
A. V. Elkin
Russian Federation
Aleksey V. Elkin, Doctor of Medical Sciences, Professor, Head of Phthisiopulmonology and Thoracic Surgery Department
47 Piskarevsky Ave., St. Petersburg, 190567
Phone: + 7 (812) 303-50-00
D. A. Smirnov
Russian Federation
Daniil A. Smirnov, the 6th Year Student of General Medicine Faculty
47 Piskarevsky Ave., St. Petersburg, 190567
Phone: + 7 (812) 303-50-00
D. A. Makarov
Russian Federation
Dmitry A. Makarov, the 6th Year Student of General Medicine Faculty
47 Piskarevsky Ave., St. Petersburg, 190567
Phone: + 7 (812) 303-50-00
A. V. Berdysheva
Russian Federation
Alena V. Berdysheva, the 6th Year Student of General Medicine Faculty
47 Piskarevsky Ave., St. Petersburg, 190567
Phone: + 7 (812) 303-50-00
References
1. Dzherieva I.S., Volkova N.I., Davidenko I.Yu., Reshetnikov I.B., Brovkina S.S., Avakova S.M., Tischenko Yu.V. Glucocorticoid therapy is a risk factor for cardiovascular diseases. Medical Herald of the South of Russia, 2022, vol. 13, no. 3, pp. 93-106. (In Russ.) https://doi.org/10.21886/2219-8075-2022-13-3-93-106
2. Zykova A.S., Novikov P.I., Moiseev S.V. Adult dermatomyositis: new classification criteria and modern treatment. Clin. Pharmacol. Ther., 2017, vol. 26, no. 2, pp. 83-92. (In Russ.)
3. Kondakova M.N., Kovaleva R.G., Elkin A.V., Khabirov V.V. Voprosy patogeneza tuberkuleza v sovremennykh nauchnykh issledovaniyakh: uchebno-metodicheskoye posobiye dlya obuchayushchikhsya po spetsialnosti 31.05.01 Lechebnoye delo. [Issues of tuberculosis pathogenesis in modern scientific research: a teaching aid for students majoring in 31.05.01. General Medicine]. North-Western State Medical University named after I.I.Mechnikov, Phthisiopulmonology and Thoracic Surgery Department. vol., part 1. St. Petersburg, 2021, 51 p.
4. Nechaeva O.B., Son I.M., Gordina A.V., Sterlikov S.A., Kucheryavaya D.A., Dergachev A.V., Ponomarev S.B. Resursy i deyatelnost protivotuberkuleznoy organizatsii v 2019-2020 gg. (statisticheskiye matarialy). [Resources and activities of TB units in 2019-2020. (Statistic materials)]. Moscow, RIO TSNIIOIZ Publ., 2021, 112 p.
5. Orlova E.V., Plieva L.R., Pyatilova P.M., Novosartyan M.G. Dermatomyositis: a clinical case and literature review. RMJ, Meditsinskoe Obozrenie, 2017, no. 11, pp. 850-852. (In Russ.)
6. Plotkin D.V., Titomer A.I., Reshetnikov M.N., Schastlivtsev I.V., Loskareva E.O., Ivanova D.A., Sinitsyn M.V., Bogorodskaya E.M. Venous thromboemboliс complications and tuberculosis: is there an interaction? Tuberculosis and Socially Significant Diseases, 2023, vol. 11, no. 4, pp. 47-56. (In Russ.) https://doi.org/10.54921/2413-0346-2023-11-4-47-57
7. Federalnye klinicheskiye rekomendatsii po okazaniyu meditsinskoy pomoschi detyam s yuvenilnym dermatomiozitom. [Federal clinical guidelines for providing medical care to children with juvenile dermatomyositis]. Soyuz Pediatrov Rossii Publ., Moscow, 2015, 25 p.
8. Bendewald M.J., Wetter D.A., Li X., Davis M.D. Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota. Archives of Dermatology, 2010, vol. 146, no. 1, pp. 26-30.
9. Callen J., Wortmann R. Dermatomyositis. Clin. Dermatol., 2006, vol. 24, no. 5, pp. 363-373.
10. Dalakas M. Inflammatory muscle diseases. N. Engl. J. Med., 2015, vol. 372, no. 18, pp. 1734-1747.
11. Spelta K., Diniz L.M. Cutaneous tuberculosis: a 26-year retrospective study in an endemic area of tuberculosis, Victoria, Espirito Santo, Brazil. Rev. Inst. Med. Trop. S. Paulo, 2016, no. 58, pp. 49.
12. Steffel J., Verhamme P., Potpara T.S., Albaladejo P., Antz M., Desteghe L. et al. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. European Heart Journal, 2018, vol. 39, no. 16, pp. 1330-1393.
13. White N.W. Venous thrombosis and rifampicin. Lancet, 1989, vol. 8660, no. 2, pp. 434-435. https://doi.org/10.1016/s0140-6736(89)90603-x)90603-x
Review
For citations:
Kovaleva R.G., Kondakova M.N., Elkin A.V., Smirnov D.A., Makarov D.A., Berdysheva A.V. Skin Dermatomyositis with Concurrent Cutaneous Tuberculosis. A Clinical Case. Tuberculosis and Lung Diseases. 2025;103(3):103-108. (In Russ.) https://doi.org/10.58838/2075-1230-2025-103-3-103-108